He will be responsible for the company's overall strategy and provide the necessary direction and dynamic leadership to R&D, manufacturing, business development, and commercial operations
Centre at Sree Chitra Tirunal Institute for Medical Sciences and Technology
He will be stationed at the company HQ in Bengaluru, India
Whole-genome sequencing to identify genetic mutation; epidemiological studies to help assess the distribution and mathematical modelling to forecast spread
Deal for 100 million doses with additional 100 million through 2023
Innovative solutions and a deep understanding of the market makes this a unique combination
Reinforcing position as a premier provider of end-to-end research intelligence solutions for Life Sciences
Startup receives US $ 5 million in first round of funding
_logo_256_384.jpg){kind=logo}
It supports sequencing-based COVID 19 surveillance in India
Subscribe To Our Newsletter & Stay Updated
